Esperite N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 nov 2012 - 07:19
Statutaire naam
Esperite N.V.
Titel
Cryo-Save Group N.V.: Q3 Trading Update - Restructuring and cost saving programs have positive impact
Bericht
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 30 September 2012.
Group revenue stabilised at €9.3 million, with the positive impact of restructuring projects and cost saving programs coming through. Most European countries showed stable storage volumes in comparison to the second quarter, whilst India achieved considerably higher storage numbers.
As a result, the Group's net profit of €0.5 million was notably higher than the previous two quarters of 2012 and was in line with expectations.
Cash and cash equivalents remained robust at €6.0 million at 30 September 2012, the same level as Q2 2012.
Datum laatste update: 27 juli 2024